p21/WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival
1996

p21 Protein Expression in Breast Cancer

Sample size: 91 publication Evidence: moderate

Author Information

Author(s): M Barbareschi, Caffo, C Doglioni, P Fina, A Marchetti, F Buttitta, R Leek, L Morelli, E Leonardi, G Bevilacqua, P Dalla Palma, AL Harris

Primary Institution: S. Chiara Hospital, Trento, Italy

Hypothesis

How does p21 expression correlate with clinicopathological data and relapse-free survival in breast carcinoma?

Conclusion

High p21 expression is associated with short relapse-free survival in breast cancer patients.

Supporting Evidence

  • High p21 expression was seen in 24 (26%) cases, associated with high tumour grade.
  • p21 expression in cases with p53 gene mutations was low in six cases and high in one.
  • Statistical analysis showed a significant relationship between high p21 expression and short relapse-free survival.

Takeaway

This study looked at a protein called p21 in breast cancer and found that when there's a lot of it, patients tend to have shorter times without cancer returning.

Methodology

The study involved immunohistochemical analysis of p21 expression in 91 breast carcinoma samples, with follow-up data collected over a median of 58 months.

Limitations

The small and heterogeneous number of cases may bias the survival analysis.

Participant Demographics

Patients included 57 node-negative and 34 node-positive breast carcinoma cases.

Statistical Information

P-Value

0.003

Statistical Significance

p=0.003

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication